These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15680720)

  • 1. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making?
    Wichter T; Breithardt G
    J Am Coll Cardiol; 2005 Feb; 45(3):409-11. PubMed ID: 15680720
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of sudden cardiac deaths in arrhythmogenic right ventricular cardiomyopathy: how to evaluate risk and when to implant a cardioverter-defibrillator?
    Woźniak O; Włodarska EK
    Cardiol J; 2009; 16(6):588-91. PubMed ID: 19950101
    [No Abstract]   [Full Text] [Related]  

  • 3. Arrhythmogenic right ventricular dysplasia: from genetics to treatment.
    Khan A; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():24-31. PubMed ID: 20089484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
    Peters S
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).
    Hodgkinson KA; Parfrey PS; Bassett AS; Kupprion C; Drenckhahn J; Norman MW; Thierfelder L; Stuckless SN; Dicks EL; McKenna WJ; Connors SP
    J Am Coll Cardiol; 2005 Feb; 45(3):400-8. PubMed ID: 15680719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arrhythmogenic right-ventricular cardiomyopathy: different manifestations as precursors of sudden death which might be prevented].
    van der Harst P; Wiesfeld AC; van Gelder IC; van Tintelen JP; Suurmeijer AJ; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2396-402. PubMed ID: 15615276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy.
    Inciardi RM; Rotolo A; Coppola G; Clemenza F; Giordano U; Lombardo E; Schicchi R; Torcivia R; Arrotti S; Leggio G; Novo S; Assennato P
    Int J Cardiol; 2014 Apr; 172(3):e468-9. PubMed ID: 24485618
    [No Abstract]   [Full Text] [Related]  

  • 8. Arrhythmogenic right ventricular dysplasia: a United States experience.
    Dalal D; Nasir K; Bomma C; Prakasa K; Tandri H; Piccini J; Roguin A; Tichnell C; James C; Russell SD; Judge DP; Abraham T; Spevak PJ; Bluemke DA; Calkins H
    Circulation; 2005 Dec; 112(25):3823-32. PubMed ID: 16344387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.
    Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE;
    Eur Heart J; 2001 Jul; 22(13):1074-81. PubMed ID: 11428848
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sudden death in young men due to arrhythmogenic right ventricular dysplasia].
    Van Langen IM; Wilde AA; Mannens MA
    Ned Tijdschr Geneeskd; 1998 Mar; 142(13):739-40. PubMed ID: 9623151
    [No Abstract]   [Full Text] [Related]  

  • 12. Arrhythmogenic right ventricular cardiomyopathy 2012: diagnostic challenges and treatment.
    Marcus FI; Abidov A
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1149-53. PubMed ID: 22909229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic Cardiomyopathy.
    Corrado D; Basso C; Judge DP
    Circ Res; 2017 Sep; 121(7):784-802. PubMed ID: 28912183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic right ventricular cardiomyopathy.
    Pike R
    Can J Cardiovasc Nurs; 2009; 19(2):5-9. PubMed ID: 19517899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative technique for implanting an epicardial cardioverter defibrillation patch during a tricuspid valve replacement for arrhythmogenic right ventricular cardiomyopathy.
    Yoda M; Tanabe H; Kishi M; Suma H
    Interact Cardiovasc Thorac Surg; 2011 Apr; 12(4):628-30. PubMed ID: 21220415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic right ventricular cardiomyopathy with implantable cardioverter defibrillator placement in pregnancy.
    Doyle NM; Monga M; Montgomery B; Dougherty AH
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):141-4. PubMed ID: 16203602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification for sudden death in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Tadros R; Talajic M; Rivard L; Abadir S; Khairy P
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):653-64. PubMed ID: 25947965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic right ventricular dysplasia and the implantable cardioverter-defibrillator: a case report and review of the literature.
    Cohen TJ; Zadeh H; Fruauff A; Klein J
    J Invasive Cardiol; 2000 Aug; 12(8):422-4. PubMed ID: 10953107
    [No Abstract]   [Full Text] [Related]  

  • 19. Left ventricular sensing and pacing for sensing difficulties in internal cardioverter defibrillator therapy for arrhythmogenic right ventricular cardiomyopathy.
    Lochy S; François B; Hollanders G; Provenier F
    Europace; 2010 Aug; 12(8):1195-6. PubMed ID: 20348554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.